Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 371

1.

[FreeSurfer as a Platform for Associating Brain Structure with Function].

Fujihara K, Takei Y.

Brain Nerve. 2018 Jul;70(7):841-848. doi: 10.11477/mf.1416201085. Japanese.

PMID:
29997280
2.

CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications.

Kaneko K, Sato DK, Nakashima I, Ogawa R, Akaishi T, Takai Y, Nishiyama S, Takahashi T, Misu T, Kuroda H, Tanaka S, Nomura K, Hashimoto Y, Callegaro D, Steinman L, Fujihara K, Aoki M.

J Neurol Neurosurg Psychiatry. 2018 Jun 6. pii: jnnp-2018-317969. doi: 10.1136/jnnp-2018-317969. [Epub ahead of print]

3.

A Case of Transient Pulmonary Interstitial Lesions in Aquaporin-4-positive Neuromyelitis Optica Spectrum Disorder.

Asato Y, Kamitani T, Ootsuka K, Kuramochi M, Nakanishi K, Shimada T, Takahashi T, Misu T, Aoki M, Fujihara K, Kawabata Y.

Intern Med. 2018 May 18. doi: 10.2169/internalmedicine.0580-17. [Epub ahead of print]

4.

Malondialdehyde-modified LDL-related variables are associated with diabetic kidney disease in type 2 diabetes.

Furukawa S, Suzuki H, Fujihara K, Kobayashi K, Iwasaki H, Sugano Y, Yatoh S, Sekiya M, Yahagi N, Shimano H.

Diabetes Res Clin Pract. 2018 Jul;141:237-243. doi: 10.1016/j.diabres.2018.05.019. Epub 2018 May 26.

PMID:
29775676
5.

Fingolimod-associated PML with mild IRIS in MS: A clinicopathologic study.

Nishiyama S, Misu T, Shishido-Hara Y, Nakamichi K, Saijo M, Takai Y, Takei K, Yamamoto N, Kuroda H, Saito R, Watanabe M, Tominaga T, Nakashima I, Fujihara K, Aoki M.

Neurol Neuroimmunol Neuroinflamm. 2017 Nov 10;5(1):e415. doi: 10.1212/NXI.0000000000000415. eCollection 2018 Jan.

6.

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing.

Jarius S, Paul F, Aktas O, Asgari N, Dale RC, de Seze J, Franciotta D, Fujihara K, Jacob A, Kim HJ, Kleiter I, Kümpfel T, Levy M, Palace J, Ruprecht K, Saiz A, Trebst C, Weinshenker BG, Wildemann B.

J Neuroinflammation. 2018 May 3;15(1):134. doi: 10.1186/s12974-018-1144-2. Review.

7.

Cardiovascular Disease in Japanese Patients with Type 2 Diabetes Mellitus.

Fujihara K, Sone H.

Ann Vasc Dis. 2018 Mar 25;11(1):2-14. doi: 10.3400/avd.ra.17-00109. Review.

8.

MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder.

Dos Passos GR, Oliveira LM, da Costa BK, Apostolos-Pereira SL, Callegaro D, Fujihara K, Sato DK.

Front Neurol. 2018 Apr 4;9:217. doi: 10.3389/fneur.2018.00217. eCollection 2018. Review.

9.

γ-Aminobutyric acid type A receptor binding affinity in the right inferior frontal gyrus at resting state predicts the performance of healthy elderly people in the visual sustained attention test.

Kasagi M, Motegi T, Narita K, Fujihara K, Suzuki Y, Tagawa M, Ujita K, Shimada H, Fukuda M.

Int Psychogeriatr. 2018 Mar 21:1-7. doi: 10.1017/S1041610217002988. [Epub ahead of print]

PMID:
29559018
10.

Severe aquaporin 4-IgG-positive neuromyelitis optica with disseminated herpes zoster in a pregnant woman successfully treated with intravenous immunoglobulin.

Matsumoto Y, Tsuchiya M, Norshalena S, Kaneko C, Kubo J, Yamamoto T, Takahashi T, Fujihara K.

Mult Scler J Exp Transl Clin. 2018 Mar 9;4(1):2055217318758119. doi: 10.1177/2055217318758119. eCollection 2018 Jan-Mar.

11.

Association between Scale-Free Brain Dynamics and Behavioral Performance: Functional MRI Study in Resting State and Face Processing Task.

Kasagi M, Huang Z, Narita K, Shitara H, Motegi T, Suzuki Y, Fujihara K, Tanabe S, Kosaka H, Ujita K, Fukuda M, Northoff G.

Behav Neurol. 2017;2017:2824615. doi: 10.1155/2017/2824615. Epub 2017 Dec 21.

12.

Children with myelin oligodendrocyte glycoprotein antibodies-associated disease: relation of phenotypes to central nervous system myelin maturation.

Kuroda H, Fujihara K.

Dev Med Child Neurol. 2018 Apr;60(4):339-340. doi: 10.1111/dmcn.13691. Epub 2018 Feb 6. No abstract available.

PMID:
29405285
13.

Role of fatty liver in the association between obesity and reduced hepatic insulin clearance.

Matsubayashi Y, Yoshida A, Suganami H, Ishiguro H, Yamamoto M, Fujihara K, Kodama S, Tanaka S, Kaku K, Sone H.

Diabetes Metab. 2018 Mar;44(2):135-142. doi: 10.1016/j.diabet.2017.12.003. Epub 2017 Dec 11.

PMID:
29395810
14.

Bridging the molecular divide: alcohol-induced downregulation of PAX9 and tumour development.

Fujihara KM, Clemons NJ.

J Pathol. 2018 Apr;244(4):386-388. doi: 10.1002/path.5041. Epub 2018 Feb 26.

PMID:
29344962
15.

Nationwide epidemiological study of neuromyelitis optica in Japan.

Miyamoto K, Fujihara K, Kira JI, Kuriyama N, Matsui M, Tamakoshi A, Kusunoki S.

J Neurol Neurosurg Psychiatry. 2018 Jun;89(6):667-668. doi: 10.1136/jnnp-2017-317321. Epub 2018 Jan 11. No abstract available.

PMID:
29326292
16.

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.

Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA.

Lancet Neurol. 2018 Feb;17(2):162-173. doi: 10.1016/S1474-4422(17)30470-2. Epub 2017 Dec 21. Review.

PMID:
29275977
17.

Relationships among cardiorespiratory fitness, muscular fitness, and cardiometabolic risk factors in Japanese adolescents: Niigata screening for and preventing the development of non-communicable disease study-Agano (NICE EVIDENCE Study-Agano) 2.

Morikawa SY, Fujihara K, Hatta M, Osawa T, Ishizawa M, Yamamoto M, Furukawa K, Ishiguro H, Matsunaga S, Ogawa Y, Shimano H, Sone H.

Pediatr Diabetes. 2018 Jun;19(4):593-602. doi: 10.1111/pedi.12623. Epub 2017 Dec 19.

PMID:
29266622
18.

Cognitive impairment in neuromyelitis optica spectrum disorders: A comparison of the Wechsler Adult Intelligence Scale-III and the Wechsler Memory Scale Revised with the Rao Brief Repeatable Neuropsychological Battery.

Fujimori J, Nakashima I, Baba T, Meguro Y, Ogawa R, Fujihara K.

eNeurologicalSci. 2017 Sep 21;9:3-7. doi: 10.1016/j.ensci.2017.09.001. eCollection 2017 Dec.

19.

Meat intake and incidence of cardiovascular disease in Japanese patients with type 2 diabetes: analysis of the Japan Diabetes Complications Study (JDCS).

Horikawa C, Kamada C, Tanaka S, Tanaka S, Araki A, Ito H, Matsunaga S, Fujihara K, Yoshimura Y, Ohashi Y, Akanuma Y, Sone H; Japan Diabetes Complications Study Group.

Eur J Nutr. 2017 Dec 8. doi: 10.1007/s00394-017-1592-y. [Epub ahead of print]

PMID:
29222638
20.

Predictors of the response of HbA1c and body weight after SGLT2 inhibition.

Abe T, Matsubayashi Y, Yoshida A, Suganami H, Nojima T, Osawa T, Ishizawa M, Yamamoto M, Fujihara K, Tanaka S, Kaku K, Sone H.

Diabetes Metab. 2018 Mar;44(2):172-174. doi: 10.1016/j.diabet.2017.10.003. Epub 2017 Nov 8. No abstract available.

PMID:
29128289
21.

Quantitative Relationship Between Cumulative Risk Alleles Based on Genome-Wide Association Studies and Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis.

Kodama S, Fujihara K, Ishiguro H, Horikawa C, Ohara N, Yachi Y, Tanaka S, Shimano H, Kato K, Hanyu O, Sone H.

J Epidemiol. 2018 Jan 5;28(1):3-18. doi: 10.2188/jea.JE20160151. Epub 2017 Oct 25. Review.

22.

Impact of body mass index and metabolic phenotypes on coronary artery disease according to glucose tolerance status.

Fujihara K, Matsubayashi Y, Yamamoto M, Osawa T, Ishizawa M, Kaneko M, Matsunaga S, Kato K, Seida H, Yamanaka N, Kodama S, Sone H.

Diabetes Metab. 2017 Dec;43(6):543-546. doi: 10.1016/j.diabet.2017.08.002. Epub 2017 Sep 14.

PMID:
28918195
23.

Association between all-cause mortality and severity of depressive symptoms in patients with type 2 diabetes: Analysis from the Japan Diabetes Complications Study (JDCS).

Matsunaga S, Tanaka S, Fujihara K, Horikawa C, Iimuro S, Kitaoka M, Sato A, Nakamura J, Haneda M, Shimano H, Akanuma Y, Ohashi Y, Sone H.

J Psychosom Res. 2017 Aug;99:34-39. doi: 10.1016/j.jpsychores.2017.05.020. Epub 2017 May 31.

PMID:
28712428
24.

Differential diagnosis of neuromyelitis optica spectrum disorders.

Kim SM, Kim SJ, Lee HJ, Kuroda H, Palace J, Fujihara K.

Ther Adv Neurol Disord. 2017 Jul;10(7):265-289. doi: 10.1177/1756285617709723. Epub 2017 May 24. Review.

25.

Relapsing optic neuritis and isolated transverse myelitis are the predominant clinical phenotypes for patients with antibodies to myelin oligodendrocyte glycoprotein in India.

Pandit L, Sato DK, Mustafa S, Takahashi T, D'Cunha A, Malli C, Sudhir A, Fujihara K.

Mult Scler J Exp Transl Clin. 2016 Oct 24;2:2055217316675634. doi: 10.1177/2055217316675634. eCollection 2016 Jan-Dec.

26.

Triterpenoid saponins from Polaskia chichipe Backbg. and their inhibitory or promotional effects on the melanogenesis of B16 melanoma cells.

Fujihara K, Takahashi K, Koyama K, Kinoshita K.

J Nat Med. 2017 Oct;71(4):606-616. doi: 10.1007/s11418-017-1082-9. Epub 2017 May 11.

PMID:
28497306
27.

Inhibition of amyloid β aggregation and protective effect on SH-SY5Y cells by triterpenoid saponins from the cactus Polaskia chichipe.

Fujihara K, Koike S, Ogasawara Y, Takahashi K, Koyama K, Kinoshita K.

Bioorg Med Chem. 2017 Jul 1;25(13):3377-3383. doi: 10.1016/j.bmc.2017.04.023. Epub 2017 Apr 22.

PMID:
28478866
28.

Disruption of the leptomeningeal blood barrier in neuromyelitis optica spectrum disorder.

Asgari N, Flanagan EP, Fujihara K, Kim HJ, Skejoe HP, Wuerfel J, Kuroda H, Kim SH, Maillart E, Marignier R, Pittock SJ, Paul F, Weinshenker BG.

Neurol Neuroimmunol Neuroinflamm. 2017 Apr 21;4(4):e343. doi: 10.1212/NXI.0000000000000343. eCollection 2017 Jul.

29.

Neuromyelitis Optica Spectrum Disorders.

Akaishi T, Nakashima I, Sato DK, Takahashi T, Fujihara K.

Neuroimaging Clin N Am. 2017 May;27(2):251-265. doi: 10.1016/j.nic.2016.12.010. Epub 2017 Feb 9. Review.

PMID:
28391784
30.

Whole brain and grey matter volume of Japanese patients with multiple sclerosis.

Akaishi T, Nakashima I, Mugikura S, Aoki M, Fujihara K.

J Neuroimmunol. 2017 May 15;306:68-75. doi: 10.1016/j.jneuroim.2017.03.009. Epub 2017 Mar 16.

PMID:
28385190
31.

Bilateral frontal cortex encephalitis and paraparesis in a patient with anti-MOG antibodies.

Fujimori J, Takai Y, Nakashima I, Sato DK, Takahashi T, Kaneko K, Nishiyama S, Watanabe M, Tanji H, Kobayashi M, Misu T, Aoki M, Fujihara K.

J Neurol Neurosurg Psychiatry. 2017 Jun;88(6):534-536. doi: 10.1136/jnnp-2016-315094. Epub 2017 Feb 16. No abstract available.

PMID:
28209651
32.

Comparison of baseline characteristics and clinical course in Japanese patients with type 2 diabetes among whom different types of oral hypoglycemic agents were chosen by diabetes specialists as initial monotherapy (JDDM 42).

Fujihara K, Igarashi R, Matsunaga S, Matsubayashi Y, Yamada T, Yokoyama H, Tanaka S, Shimano H, Maegawa H, Yamazaki K, Kawai K, Sone H.

Medicine (Baltimore). 2017 Feb;96(7):e6122. doi: 10.1097/MD.0000000000006122.

33.

MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy.

Ogawa R, Nakashima I, Takahashi T, Kaneko K, Akaishi T, Takai Y, Sato DK, Nishiyama S, Misu T, Kuroda H, Aoki M, Fujihara K.

Neurol Neuroimmunol Neuroinflamm. 2017 Jan 16;4(2):e322. doi: 10.1212/NXI.0000000000000322. eCollection 2017 Mar.

34.

Unstable bodyweight and incident type 2 diabetes mellitus: A meta-analysis.

Kodama S, Fujihara K, Ishiguro H, Horikawa C, Ohara N, Yachi Y, Tanaka S, Shimano H, Kato K, Hanyu O, Sone H.

J Diabetes Investig. 2017 Jul;8(4):501-509. doi: 10.1111/jdi.12623. Epub 2017 Apr 26.

35.

Serological markers associated with neuromyelitis optica spectrum disorders in South India.

Pandit L, Sato DK, Mustafa S, Takahashi T, D'Cunha A, Malli C, Sudhir A, Fujihara K.

Ann Indian Acad Neurol. 2016 Oct-Dec;19(4):505-509.

36.

Anti-MOG (Myelin Oligodendrocyte Glycoprotein)-Positive Severe Optic Neuritis with Optic Disc Ischaemia and Macular Star.

Moura FC, Sato DK, Rimkus CM, Apóstolos-Pereira SL, de Oliveira LM, Leite CC, Fujihara K, Monteiro ML, Callegaro D.

Neuroophthalmology. 2015 Nov 10;39(6):285-288. eCollection 2015 Dec.

37.

Reversible splenial lesion syndrome with a hyperosmolar hyperglycemic state and neuroleptic malignant syndrome caused by olanzapine.

Kaino K, Kumagai R, Furukawa S, Isono M, Muramatsu A, Fujii M, Muta Y, Asada T, Fujihara K, Yagyu H.

J Diabetes Investig. 2017 May;8(3):392-394. doi: 10.1111/jdi.12597. Epub 2017 Jan 6.

38.

Quantitative assessment of genetic testing for type 2 diabetes mellitus based on findings of genome-wide association studies.

Kodama S, Fujihara K, Ishiguro H, Horikawa C, Ohara N, Yachi Y, Tanaka S, Shimano H, Kato K, Hanyu O, Sone H.

Ann Epidemiol. 2016 Nov;26(11):816-818.e6. doi: 10.1016/j.annepidem.2016.09.004. Epub 2016 Sep 22. No abstract available.

PMID:
27751632
39.

Hypoxia-like tissue injury and glial response contribute to Balo concentric lesion development.

Takai Y, Misu T, Nishiyama S, Ono H, Kuroda H, Nakashima I, Saito R, Kanamori M, Sonoda Y, Kumabe T, Mugikura S, Watanabe M, Aoki M, Fujihara K.

Neurology. 2016 Nov 8;87(19):2000-2005. Epub 2016 Oct 12.

40.

Different etiologies and prognoses of optic neuritis in demyelinating diseases.

Akaishi T, Nakashima I, Takeshita T, Kaneko K, Mugikura S, Sato DK, Takahashi T, Nakazawa T, Aoki M, Fujihara K.

J Neuroimmunol. 2016 Oct 15;299:152-157. doi: 10.1016/j.jneuroim.2016.09.007. Epub 2016 Sep 14.

PMID:
27725114
41.

Impact of glucose tolerance status on the development of coronary artery disease among working-age men.

Fujihara K, Igarashi R, Yamamoto M, Ishizawa M, Matsubayasi Y, Matsunaga S, Kato K, Ito C, Koishi M, Yamanaka N, Kodama S, Sone H.

Diabetes Metab. 2017 Jun;43(3):261-264. doi: 10.1016/j.diabet.2016.09.001. Epub 2016 Oct 4.

PMID:
27712966
42.

Impact of individual components and their combinations within a family history of hypertension on the incidence of hypertension: Toranomon hospital health management center study 22.

Igarashi R, Fujihara K, Heianza Y, Ishizawa M, Kodama S, Saito K, Hara S, Hanyu O, Honda R, Tsuji H, Arase Y, Sone H.

Medicine (Baltimore). 2016 Sep;95(38):e4564. doi: 10.1097/MD.0000000000004564.

43.

Impact of the Great East Japan Earthquake in 2011 on MS and NMOSD: a study in Sendai, Japan.

Kanamori Y, Nakashima I, Takai Y, Misu T, Kuroda H, Nishiyama S, Takahashi T, Sato S, Fujimori J, Higuchi J, Itoyama Y, Aoki M, Fujihara K.

J Neurol Neurosurg Psychiatry. 2017 Apr;88(4):362-364. doi: 10.1136/jnnp-2016-313890. Epub 2016 Aug 17. No abstract available.

PMID:
27535942
44.

Aquaporin 4-specific T cells and NMO-IgG cause primary retinal damage in experimental NMO/SD.

Zeka B, Hastermann M, Kaufmann N, Schanda K, Pende M, Misu T, Rommer P, Fujihara K, Nakashima I, Dahle C, Leutmezer F, Reindl M, Lassmann H, Bradl M.

Acta Neuropathol Commun. 2016 Aug 8;4(1):82. doi: 10.1186/s40478-016-0355-y.

45.

Lack of KIR4.1 autoantibodies in Japanese patients with MS and NMO.

Higuchi O, Nakane S, Sakai W, Maeda Y, Niino M, Takahashi T, Fukazawa T, Kikuchi S, Fujihara K, Matsuo H.

Neurol Neuroimmunol Neuroinflamm. 2016 Jul 22;3(5):e263. doi: 10.1212/NXI.0000000000000263. eCollection 2016 Oct.

46.

Utility of nonblood-based risk assessment for predicting type 2 diabetes mellitus: A meta-analysis.

Yoshizawa S, Kodama S, Fujihara K, Ishiguro H, Ishizawa M, Matsubayashi Y, Matsunaga S, Yamada T, Shimano H, Kato K, Hanyu O, Sone H.

Prev Med. 2016 Oct;91:180-187. doi: 10.1016/j.ypmed.2016.07.026. Epub 2016 Jul 26. Review.

PMID:
27473666
47.

Fulminant Type 1 Diabetes Mellitus Presenting 11 Days after Delivery in a Patient of Mixed Genetic Background.

Furukawa S, Fujihara K, Kumagai R, Isono M, Yagyu H.

Intern Med. 2016;55(14):1881-5. doi: 10.2169/internalmedicine.55.6052. Epub 2016 Jul 15.

48.

Pioglitazone-induced Pulmonary Injury in a Very Elderly Patient.

Katayama K, Kumagai R, Isono M, Fujihara K, Yagyu H, Ohara G, Kagohashi K, Satoh H.

Intern Med. 2016;55(13):1779-82. doi: 10.2169/internalmedicine.55.6330. Epub 2016 Jul 1.

49.

[Anti-MOG + neuromyelitis optica spectrum disorders treated with plasmapheresis].

Oshiro A, Nakamura S, Tamashiro K, Fujihara K.

No To Hattatsu. 2016 May;48(3):199-203. Japanese.

PMID:
27349083
50.

Pseudo-perifascicular atrophy in the healing phase of Jo-1 antisynthetase syndrome.

Tateyama M, Shibuya S, Sato H, Fujihara K, Aoki M.

Neuromuscul Disord. 2016 Aug;26(8):521-2. doi: 10.1016/j.nmd.2016.06.003. Epub 2016 Jun 7. No abstract available.

PMID:
27321928

Supplemental Content

Loading ...
Support Center